2012 Press Releases

Novavax’ Phase I RSV Vaccine Data Published in Vaccine
12/06/12
Novavax Publishes Preclinical Efficacy Study of its RSV Protein Nanoparticle Vaccine Candidate
12/03/12
Novavax to Present at the 24th Annual Piper Jaffray Healthcare Conference
11/20/12
Novavax to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
11/12/12
Novavax Reports Third-Quarter 2012 Financial Results
11/02/12
Novavax to Report Third Quarter 2012 Financial Results on November 2, 2012
10/26/12
Novavax Announces $27 Million Equity Offering
10/23/12
Novavax Reports Positive Top-Line Results from Two Phase 1 Trials of Pandemic Influenza Vaccine
10/17/12
Novavax Initiates Phase 1 Clinical Trial of RSV Vaccine Candidate in Elderly Adults
10/15/12
Novavax Initiates Phase 2 Clinical Trial of RSV Vaccine Candidate
10/08/12
Novavax Presents RSV Vaccine Data at the 8th Annual International Respiratory Virus Symposium
09/27/12
NOVAVAX to Present at the Rodman & Renshaw 14th Annual Healthcare Conference
09/06/12
NOVAVAX to Present at the 2012 Stifel Nicolaus Healthcare Conference
09/04/12
NOVAVAX to Present at the 2012 Wedbush Life Sciences Conference
08/13/12
NOVAVAX Reports Second Quarter 2012 Financial Results
08/03/12
NOVAVAX to Report Second Quarter 2012 Financial Results
07/27/12
NOVAVAX Provides Update on Influenza Programs
07/24/12
NOVAVAX and PATH Announce Partnership on RSV Vaccine
07/18/12
NOVAVAX, CPL Biologicals and the International Centre for Genetic Engineering and Biotechnology Announce Collaboration to Develop New Malaria Vaccine with Funding from Government of India
07/16/12
NOVAVAX Reports on Progress with RSV Vaccine at New International Conference on Modern Vaccines
07/05/12
Novavax to Review RSV Program at New International Conference on Modern Vaccines
06/27/12
NOVAVAX to Present at Jefferies 2012 Global Healthcare Conference
06/04/12
Novavax, Inc. Announces $12 Million Equity Offering
05/21/12
NOVAVAX Launches Additional Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate
05/08/12
NOVAVAX Reports First Quarter 2012 Financial Results
05/03/12
NOVAVAX Launches Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate
05/02/12
NOVAVAX to Report First Quarter 2012 Financial Results on May 4, 2012
04/26/12
NOVAVAX to Present at the 11th Annual Needham Healthcare Conference
04/03/12
NOVAVAX to Present Results from Phase I RSV Study at XIV International Symposium on Respiratory Viral Infections
03/22/12
NOVAVAX to Present at the 24th Annual ROTH Conference
03/12/12
NOVAVAX Reports Fourth Quarter and 2011 Year-End Financial Results
03/09/12
NOVAVAX Appoints John A. Herrmann III, Vice President and General Counsel
03/08/12
NOVAVAX Launches Phase II Clinical Trial of Seasonal Influenza Vaccine
03/01/12
NOVAVAX to Report 2011 Fourth-Quarter and Year-End Financial Results on March 9, 2012
02/24/12
NOVAVAX to Present at the 14th Annual Bio CEO & Investor Conference
02/10/12
NOVAVAX Appoints Mervyn L. Hamer, Vice President of Manufacturing
02/01/12
NOVAVAX Reports Progress Under Joint Venture in India with Cadila Pharmaceuticals
01/03/12